Cinolazepam
Ọdịdị
| Clinical data | |
|---|---|
| Trade names | Gerodorm |
| AHFS/Drugs.com | cinolazepam |
| Routes of administration |
Oral |
| ATC code |
|
| Ọnọdụ iwu | |
| Ọnọdụ iwu |
|
| Ihe omuma pharmacokinetic | |
| Bioavailability | 90-100% |
| Metabolism | Ọrịa imeju |
| <span class="nowrap">Ọkara ndụ</span> e wepụrụ | awa 3.8[1] |
| Mgbapụta | Akụrụ |
| Ihe ndị na-eme ka a mata ya | |
Aha IUPAC
| |
| Nọmba CAS | |
| PubChem <abbr title="<nowiki>Compound ID</nowiki>">CID | |
| Ụlọ Akụ̀ Ọgwụ | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI |
|
| ChEMBL | |
| Ihe omuma kemịkal na nke anụ ahụ | |
| Nhazi | C18H13ClFN3O2 |
| Ọkpụkpụ nke ọkpụkpụ | 357.8 g·mol-1 |
| Ihe nlereanya 3D (JSmol) | |
| Chirality | Ngwakọta agbụrụ |
Mmetụta ihere
| |
InChI
| |
| NY (gịnị bụ nke a? | |
Cinolazepam[2] (nke a na-ere n'okpuru aha Gerodorm) bụ ọgwụ nke bụ benzodiazepine.[3] Ọ nwere ihe na-eme ka nchegbu kwụsị, ihe na-egbochi nkụchi, ihe na'ime ka ọ dị jụụ na ihe na-ehi ụra. N'ihi ikike ya ahazi na ụdị nke ụwa na ụdị ke amụta site na iji Tinye na Enyi siri ike, a na-eji ya eme ihe dị ka ọgwụ na-eme ka mmadụ kwụsị.
E nyere ya ikike n'afọ 1978 ma malite iji ya mee ihe n'ụzọ ọgwụ na 1992.[4] A kwadoghị Cinolazepam maka ire ere na United States ma ọ bụ Canada.
Ntụaka
[dezie | dezie ebe o si]- ↑ "ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS" (Press release). (in Austrian German). Austria: G.L. Pharma GmbH. Bundesamt für Sicherheit im Gesundheitswesen. October 2018. Archived from the original on 2019-01-02. Retrieved 2019-01-02.
- ↑ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
- ↑ Lannacher Romania (1999). Gerodorm (ro). Produse Gerot inregistrate in Romania. Archived from the original on 11 October 2006. Retrieved on 17 August 2006.
- ↑ (2006) Analogue-based Drug Discovery (in en). John Wiley & Sons. ISBN 9783527607495.